TB-500 Dosage Guide
Complete guide to TB-500 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
2 mg – 2.5 mg
Frequency
Once per week
Route
subcutaneous
Cycle Length
4–8 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.
Administration Method
Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.900 ml
Syringe units: 90.0 units
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with TB-500 defaults. Adjust values as needed.
Side Effects to Monitor
May cause temporary fatigue, headache, or localized irritation at injection sites.
Safety Considerations & Risks
Theoretical concerns about promoting growth of existing cancers due to angiogenic properties. Not approved for human use.